Latest Cancer News

Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer (02-27-2015)
The results of the phase II PALOMA-1/TRIO-18 trial were recently reported in The Lancet Oncology and suggest that the addition of Ibrance® (palbociclib) to Femara® (letrozole) delayed the time to cancer... Continue Reading

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (02-26-2015)
The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment... Continue Reading

Farydak® Approval Provides Another Treatment Option for Patients With Multiple Myeloma (02-25-2015)
Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat) in combination with Velcade® and dexamethasone for the treatment of patients with multiple... Continue Reading

More Cancer News

Locations

La Jolla Location
9850 Genesee Ave
Ste 830
La Jolla, CA 92037
858.552.1410
Fax: 858.552.0929
click here for directions
Encinitas Location
477 N. El Camino Real
Ste D200
Encinitas, CA  92024
760.452.3340
Fax: 760.452.3344
click here for directions
Vista Location
161 Thunder Drive
Ste 106
Vista, CA  92083
760.208.6730
Fax: 760.208.6736
click here for directions
Escondido Location
625 W. Citracado Parkway
Suite 110
Escondido, CA  92025
760.747.8935
Fax: 760.747.7951
click here for directions
4 S Ranch Location
16918 Dove Canyon Road
San Diego, CA 92127
Ste 103
858-649-5100
Fax: 858-649-5099
click here for directions
La Jolla Urology
9834 Genesee Ave
Ste 416
La Jolla, CA 92037
858.458.0099
Fax: 858.429.7935
click here for directions
Temecula
31720 Temecula Pkwy
Ste 200
Temecula, CA 92592
Ph: 760.452.3340
click here for directions